Dyne Therapeutics, Inc. (DYN)
26.50
+0.51
(+1.96%)
USD |
NASDAQ |
Aug 25, 09:36
Dyne Therapeutics 1 Year Total Returns (Daily) : 106.6% for Aug. 24, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 24, 2026 | 106.6% |
| August 21, 2026 | 113.6% |
| August 20, 2026 | 117.0% |
| August 19, 2026 | 118.6% |
| August 18, 2026 | 110.9% |
| August 17, 2026 | 111.2% |
| August 14, 2026 | 105.6% |
| August 13, 2026 | 112.1% |
| August 12, 2026 | 125.2% |
| August 11, 2026 | 137.6% |
| August 10, 2026 | 137.5% |
| August 07, 2026 | 134.6% |
| August 06, 2026 | 123.3% |
| August 05, 2026 | 150.0% |
| August 04, 2026 | 153.4% |
| August 03, 2026 | 151.1% |
| July 31, 2026 | 155.6% |
| July 30, 2026 | 159.6% |
| July 29, 2026 | 172.8% |
| July 28, 2026 | 178.2% |
| July 27, 2026 | 157.6% |
| July 24, 2026 | 164.5% |
| July 23, 2026 | 154.7% |
| July 22, 2026 | 152.0% |
| July 21, 2026 | 159.9% |
| Date | Value |
|---|---|
| July 20, 2026 | 160.0% |
| July 17, 2026 | 152.6% |
| July 16, 2026 | 143.5% |
| July 15, 2026 | 189.7% |
| July 14, 2026 | 166.9% |
| July 13, 2026 | 173.6% |
| July 10, 2026 | 166.1% |
| July 09, 2026 | 173.3% |
| July 08, 2026 | 184.0% |
| July 07, 2026 | 191.3% |
| July 06, 2026 | 160.7% |
| July 02, 2026 | 158.1% |
| July 01, 2026 | 151.0% |
| June 30, 2026 | 133.3% |
| June 29, 2026 | 122.2% |
| June 26, 2026 | 108.4% |
| June 25, 2026 | 97.79% |
| June 24, 2026 | 91.25% |
| June 23, 2026 | 99.41% |
| June 22, 2026 | 102.2% |
| June 18, 2026 | 83.67% |
| June 17, 2026 | 76.80% |
| June 16, 2026 | 30.75% |
| June 15, 2026 | 29.98% |
| June 12, 2026 | 25.80% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Vor Biopharma, Inc. | -47.67% |
| Neurocrine Biosciences, Inc. | 13.00% |
| Recursion Pharmaceuticals, Inc. | -34.21% |
| Agenus, Inc. | 69.69% |
| Amgen, Inc. | 55.28% |